Skylight Investment

B9 is an on-demand income streaming platform assisting employees to gain control over their finances, including their ability to receive earned paycheck without having to wait until payday. It provides their customers with suite of financial wellness benefits, and access to modern banking.

Cardea Bio Inc. is a biotechnology company based in San Diego, California, that specializes in the development, manufacturing, and commercialization of graphene-based digital biosensor hardware, software, and molecular infrastructure. Founded in 2013, the company focuses on enhancing precision healthcare through innovative products that improve the ease, speed, and cost of diagnostics. Its insight biosensors utilize graphene to convert biomolecular interactions into digital signals, facilitating direct access to biological data. Cardea offers various products, including the AGILE R100 for small molecule drug discovery and the AGILE R200, an automated high-throughput screening solution. The company's technology enables real-time analysis of biological signals, which is valuable for life sciences and healthcare applications. Cardea Bio also provides diagnostic tests for conditions such as Lyme disease, contributing to advancements in biomolecular analysis and antibody development.

Butlr Technologies Inc. develops a wireless sensor system that captures and transmits real-time data on human movement and behavior in various environments, particularly in retail and hospitality. Founded in 2019 and based in Burlingame, California, Butlr's technology combines proprietary hardware with advanced artificial intelligence to analyze location and duration data, translating it into insights about consumer preferences and behaviors. The company's low-cost thermal imaging system gained attention during the coronavirus pandemic as a tool to protect the health of employees and customers. Unlike traditional cameras, Butlr's sensors detect unique biometric heat signatures, allowing for privacy-preserving monitoring while enabling businesses to optimize their spaces. This technology has broader implications, with a vision for responsive architecture that adapts environments based on real-time data, potentially enhancing urban infrastructure by predicting and responding to dynamic conditions such as pedestrian traffic and weather changes.

Tivic Health is a bioelectronic therapeutics company. We translate neuroscience into consumer-friendly medical devices, expanding the role of bioelectronic therapies in the healthcare ecosystem. Their first innovation, ClearUP™ Sinus Pain Relief, delivers temporary relief of sinus pain. It’s a small handheld device that’s easy to use, re-usable, and clinically proven. The company received FDA Clearance January 2, 2019 and will be shipping product in September 2019.

Valitor, Inc. is a biotechnology company founded in 2010 and based in Berkeley, California. The company focuses on developing advanced, protein-based drugs and has established innovative methods to modify therapeutic proteins, enhancing their pharmacokinetics, target specificity, and bioactivity. Valitor's technology platform is versatile and can be applied to improve the pharmacological properties of various protein drugs, whether approved or in development. The company is currently advancing three development pipelines in the fields of dermatology, ophthalmology, and orthopedics, showcasing the potential of its novel drug products.

Our Mission: Let artificial intelligence penetrate to every industry Our Vision: Short-Term: Build an authoritative, reliable, and trustworthy trading platform to link artificial intelligence services by docking buyers and sellers globally. Mid-Term: Empower growth of Chinese AI industry and contribute to the global development of artificial intelligence. Long-Term: Create a global artificial intelligence ecosystem which established, owned, and shared by every people

Tivic Health is a bioelectronic therapeutics company. We translate neuroscience into consumer-friendly medical devices, expanding the role of bioelectronic therapies in the healthcare ecosystem. Their first innovation, ClearUP™ Sinus Pain Relief, delivers temporary relief of sinus pain. It’s a small handheld device that’s easy to use, re-usable, and clinically proven. The company received FDA Clearance January 2, 2019 and will be shipping product in September 2019.